Cancer chemoresistance; biochemical and molecular aspects: a brief overview
- 16 April 2016
- journal article
- review article
- Published by Elsevier BV in European Journal of Pharmaceutical Sciences
- Vol. 89, 20-30
- https://doi.org/10.1016/j.ejps.2016.03.025
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Tyrosine kinase inhibitors as modulators of ABC transporter-mediated drug resistanceDrug Resistance Updates, 2012
- Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistanceBiochemical Pharmacology, 2012
- Methotrexate induces oxidative DNA damage and is selectively lethal to tumour cells with defects in the DNA mismatch repair gene MSH2EMBO Molecular Medicine, 2009
- ABC transporters: the power to changeNature Reviews Molecular Cell Biology, 2009
- Targeting multidrug resistance in cancerNature Reviews Drug Discovery, 2006
- The role of apoptosis in cancer development and treatment responseNature Reviews Cancer, 2005
- Small interfering RNA-induced suppression of ERCC1 enhances sensitivity of human cancer cells to cisplatinBiochemical and Biophysical Research Communications, 2005
- Molecular mechanisms of drug resistanceThe Journal of Pathology, 2005
- Intrinsic tumour suppressionNature, 2004
- Multidrug resistance in cancer: role of ATP–dependent transportersNature Reviews Cancer, 2002